Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.
about
Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysisPharmacotherapy for anxiety disorders in children and adolescentsSevere mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.Identifying genomic and developmental causes of adverse drug reactions in children.Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'A pilot study of actigraphy as an objective measure of SSRI activation symptoms: results from a randomized placebo controlled psychopharmacological treatment studyPsychopharmacology of pediatric bipolar disorder.A systematic review of treatments for anxiety in youth with autism spectrum disorders.Update on the Use of SSRIs and SNRIs with Children and Adolescents in Clinical Practice.Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.SSRIs-Related Behavioural Syndromes in Children and Adolescents.Antidepressant-induced activation in children and adolescents: Risk, recognition and management.Anxiety Disorders and Obsessive-Compulsive Disorder in Individuals with Autism Spectrum Disorder.
P2860
Q26824097-B9B47CE3-55CA-495B-9635-A9B1A2A48869Q26853715-048D1EFE-802E-405D-A3FD-4A5C74999318Q34152823-4ABF1857-8ED6-48E6-979F-AD3D9E076247Q34603032-099AE6CF-2430-414F-AA0F-3FF11D4CFD6EQ35178499-C0850737-4FED-438B-85DF-16AB559E2558Q35595799-36112B6A-5F51-472B-B7E8-E530A3306E54Q37768441-D132EF31-1AEE-499F-A1E4-04F6344744ADQ38234796-6C2A40A5-4D84-41D4-ABA1-4BDF58512913Q38989665-0A6C2B47-41D5-48A7-94FE-1AF2C8D568EAQ39043925-94BA0DCF-B181-413D-8AD3-F4CEF0EE3207Q39285492-8D61ED9C-50DD-4A43-B955-B6C5539A31DCQ42270668-1601AAEC-F1EE-42E1-8A7F-0C7A3E1804B7Q47642434-A820E98B-E61C-4F59-B810-907F47EC03A0Q47870461-CED082C0-674F-45DB-898B-7F3B30344104
P2860
Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Activation adverse events indu ...... e in children and adolescents.
@ast
Activation adverse events indu ...... e in children and adolescents.
@en
type
label
Activation adverse events indu ...... e in children and adolescents.
@ast
Activation adverse events indu ...... e in children and adolescents.
@en
prefLabel
Activation adverse events indu ...... e in children and adolescents.
@ast
Activation adverse events indu ...... e in children and adolescents.
@en
P2093
P2860
P356
P1476
Activation adverse events indu ...... e in children and adolescents.
@en
P2093
John T Walkup
Mark A Riddle
Shauna P Reinblatt
Susan DosReis
P2860
P304
P356
10.1089/CAP.2008.040
P577
2009-04-01T00:00:00Z